Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Mater Sci Eng C Mater Biol Appl ; 107: 110270, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31761224

RESUMEN

In this study, for developing a scaffold for tissue engineering from fish processing wastes, a hierachial collagen/gelatin/chitosan novel porous scaffold was fabricated using blends of collagen and gelatin extracted from the skins of Marine big eye snapper Priacanthus humrur. Scaffolds were developed by mechanical spinning of chitosan and by mixing of collagen and gelatin solutions followed by freeze drying and subsequent crosslinking of polymers. The scaffolds were evaluated for rheological properties - porosity, apparent density and swelling capacity to assess their mechanical property.Gelatin/chitosan composition shown very high porosity(81.02%) and incorporation of collagen shown higher density in Collagen/gelatin/chitosan scaffolds (0.0522g/cm3) and collagen/chitosan scaffolds (0.0468 g/cm3).Morphology of the prepared scaffolds were analyzed by Scanning Electron Microscopy which showed reduced pore size of 10 to 20µ in Collagen/gelatin/Chitosan composite, 5 to 10µ in gelatin/chitosan composites and 2-5µ in collagen/chitosan composites. FTIR analysis showed intense peaks ranging 1120 -11267 cm-1 in the three different scaffolds that are denoted as CH groups. In-vitro antioxidant investigation through DPPH assay showed that the composite 3 in 1 mg/ml concentration exhibited higher antioxidant potential (70%). In contrast, ABTS scavenging assay identified composite1 in 1 mg/ml had good antioxidant activity with highest percentage of inhibition (29.5%). The scaffolds were also evaluated for anti microbial properties through disc diffusion assay. The results showed maximum inhibition- 14 mm, 12 mm and 14 mm for 200 µg of the sample for collagen/chitosan, gelatin/chitosan and collagen/gelatin/chitosan scaffolds respectively towards E.Coli and 20 mm, 20 mm and 24 mm towards S.aureus. The zone of inhibition against E. coli and S. aureus for the three scaffolds was comparatively lower and that could be due to the presence of chitosan. The findings of the study indicates that the bioscaffolds are expected to have wide application in tissue engineering.


Asunto(s)
Antiinfecciosos/química , Antioxidantes/química , Quitosano/química , Colágeno/química , Gelatina/química , Animales , Antiinfecciosos/farmacología , Materiales Biocompatibles/química , Materiales Biocompatibles/farmacología , Fuerza Compresiva , Pruebas Antimicrobianas de Difusión por Disco , Escherichia coli/efectos de los fármacos , Perciformes , Porosidad , Reología , Piel/efectos de los fármacos , Piel/metabolismo , Piel/patología , Staphylococcus aureus/efectos de los fármacos
2.
Environ Sci Pollut Res Int ; 23(3): 2705-14, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26438369

RESUMEN

Green synthesis of silver nanoparticles (AgNPs) using Hybanthus enneaspermus extract at room temperature that act as a reducing agent as well as capping agent has been investigated. The synthesized AgNPs were characterized by UV-visible spectroscopy, X-ray diffraction (XRD), Fourier transform infrared (FTIR), zeta potential, and dynamic light scattering (DLS) transmission electron microscopy (TEM) and energy-dispersive X-ray (EDX). The silver surface plasmon resonance was observed at 420 nm in the UV-visible spectrum. XRD peaks were observed at 2θ values in 38.20°, 44.40°, 64.60°, and 77.50° which are indexed as (111), (200), (220), and (311) bands of face-centered cubic (fcc) structures of silver. FTIR revealed the AgNPs were capped with plant compounds of alcohol, phenols, carbonyl, amines, and amide functional groups. TEM image shows that the particles were of spherical, hexagonal, and triangular in shape, and the size range was 16-26 nm. Further, DLS exhibits the average size of 25.2 nm and the zeta values were measured (-27.1 mV) which proves the stability of the AgNPs. The conversion of Ag(+) ions into Ag(0) was calculated using inductively coupled plasma atomic emission spectroscopy (ICP-MS) and was found to be 96 %. The biosynthesized AgNPs showed the larvicidal activity with the LC50 values of 17.24 and 13.12 mg/L against the fourth-instar larvae of Anopheles subpictus and Culex quinquefasciatus, respectively. The GC-MS analysis of the plant extract showed that 39 bioactive phytochemical compounds have been found to possess a wide range of activities, which may help in the protection against incurable diseases.


Asunto(s)
Insecticidas/farmacología , Nanopartículas del Metal , Plata , Violaceae/química , Animales , Anopheles , Culex , Cromatografía de Gases y Espectrometría de Masas , Insecticidas/análisis , Larva/efectos de los fármacos , Nanopartículas del Metal/química , Extractos Vegetales/química , Hojas de la Planta/química , Plata/química , Temperatura , Difracción de Rayos X
3.
Biotechnol Rep (Amst) ; 8: 110-115, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28352579

RESUMEN

A single step protocol to produce biofunctionalized silver nanoparticles (AgNPs) using the aqueous extract of Cassia fistula flower as "natural factory" was investigated. The reaction between silver ions and aqueous flower extract after the bioreduction process has resulted in the formation of reddish brown color colloidal solution. XRD pattern showed the face centered cubic crystalline structure of AgNPs and exhibited spherical morphology as characterized by FE-SEM. FTIR studies identified different functional groups involved in effective capping of AgNPs. The zeta potential affirmed the phytoreduced AgNPs possess good stability and the size of the particle was measured by DLS. The synthesized AgNPs displayed effective cytotoxic potential against MCF7 and the inhibitory concentration (IC50) was recorded at 7.19 µg/mL. The apoptotic effects of the AgNPs were also confirmed by AO/EB staining. The investigation presents preliminary evidence that biosynthesized AgNPs can be used in the development of novel anticancer drugs.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA